With FDA Chief Scott Gottlieb's departure, we're already seeing big price swings in stocks that may be affected by a change in FDA policy towards tobacco and health care companies. Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.
Analyst Articles
Given the stock market’s erratic behavior, a lot of money can be made in these three beaten-down stocks that could move strongly in the weeks to come. Read More
We sift through the Oracle of Omaha’s voluminous writings to see what they can tell us about picking winning stocks. Read More
If you want to play the biotech lottery, you need to pinpoint the companies that stand a better-than-average chance of beating the odds. Read More
Here's a look at the “FIRE” movement, which stands for Financial Independence Retire Early. A sure-fire way to retire early? Earn outsized returns. Read More
There's more risk in the market than the VIX, or “fear gauge,” would suggest. Here's how to profit from it. Read More
As we announced last week, all of our Income Millionaire subscribers will become full subscribers to the Income Trader service published by Profitable Trading starting this week. For that reason, we are providing this guidance for the open positions remaining in our portfolio. Read More
As we announced last week, all of our Systematic Wealth subscribers will become full subscribers to the Profit Amplifier trading service published by Profitable Trading starting this week. For that reason, we are providing this guidance for the open positions remaining in our portfolio. Read More
We think GE stock bottomed out two months ago and won't drop below $7 per share again. Here's a great way to profit. Read More
Can beleaguered Taronis change direction in 2019 and dominate the biofuel market, now that it has a new name, a new strategy and even a new ticker symbol? Read More